Multicenter Study Comparing Minimally Invasive Proximal Versus Total Gastrectomy
for Proximal Gastric and Gastroesophageal Junction Cancers
Led by M.D. Anderson Cancer Center · Updated on 2026-08-21
20
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare symptoms in patients with proximal gastric and gastroesophageal junction cancers who undergo two types of minimally invasive surgeries proximal gastrectomy MIPG and total gastrectomy MITG. The study focuses on evaluating short-term appetite differences and how these may affect nutritional status and body weight after surgery. It also investigates patient-reported outcomes and safety measures related to these surgical procedures.
Participants will complete questionnaires about their health, appetite, and quality of life before surgery and then at 1, 3, 6, and 12 months after surgery. The study collects data using the MD Anderson Symptom Inventory Gastrointestinal Cancer Module with additional experimental questions and measures fasting ghrelin levels to understand appetite changes. The study also looks at factors influencing quality of life, surgical safety, and cancer outcomes after each surgery type.
During the study, participants will be asked to complete brief questionnaires taking about 3 to 5 minutes each time. These assessments occur before surgery and during follow-up visits up to one year after surgery. Researchers will analyze questionnaire responses and biological markers to measure symptoms, appetite, and quality of life. The study is observational, and participants will be monitored without additional interventions beyond standard care.
CONDITIONS
Brief Title
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
Research Team
N
Naruhiko Ikoma, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Able to speak and read English, Spanish, Japanese, or Korean
Biopsy-confirmed diagnosis of non-metastatic gastric or gastroesophageal junction adenocarcinoma
Scheduled to undergo minimally invasive proximal gastrectomy (MIPG) or minimally invasive total gastrectomy (MITG) for curative intent
Age 18 years or older
You will not qualify if you...
Known malabsorption syndromes or physical integrity issues of the upper gastrointestinal tract
Known narcotic dependence with average daily dose greater than 5 mg oral morphine equivalent
Unable to comply with study and follow-up procedures as determined by investigators
Pregnant participants
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Observation and Questionnaire Completion
Duration - 12 months
Participants complete questionnaires about their health, appetite, and quality of life before surgery and at 1, 3, 6, and 12 months after surgery. These questionnaires take about 3 to 5 minutes each.
Questionnaires at 5 time points: before surgery, 1, 3, 6, and 12 months after surgery
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Phase IIIa Study Evaluating DA-3501 for Advanced Gastric, Gastro-Esophageal Junction, and Pancreatic Ductal Adenocarcinomas
Assessing Safety, Effectiveness, and Proper Dose Given Every Three Weeks
Open-label Phase 2 Study Evaluating Zanidatamab for Previously Treated HER2-expressing Solid Tumors
Phase 1 Open Label Study of MGC030 for Advanced Solid Tumors Including Dose Escalation, Optimization, and Expansion
Phase 2 Trial Comparing Standard and Extended Dosing Intervals of Nivolumab, Pembrolizumab, and Atezolizumab in Advanced Gastric, Liver, and Lung Cancers
Adjuvant Chemotherapy and Immunotherapy After Surgery for Esophageal and Esophageal-Gastric Junction Cancer With High Risk of Recurrence
Phase 12a Study Evaluating MDX2001 Monotherapy for Advanced Solid Tumors
A Multicenter, Open-label Clinical Trial Assessing Safety and Anti-tumor Activity
Ultrasound-Guided External Oblique Intercostal Block to Reduce Pain in Children Having Laparoscopic Gastrostomy
Testing a New Constant Pressure Skin Disk Device for Feeding Tubes in Adults Undergoing Gastrostomy or Jejunostomy Tube Placement
Study of Immune Changes in Tumor Environment During Standard Chemotherapy for Localized and Resectable Gastric and Gastroesophageal Junction Cancers
Using Nasopharyngeal Airway and Nasal High-flow Oxygen Therapy
During Painless Gastroscopy in Adults with Obesity
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers.
Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results.